Showing results (51-60 of 220) with videos related to
Sort By:
Pageof 22
Annals of Clinical Research|January 1, 1984
Factors predicting remission in type I diabetesR Pelkonen, A AroThrombosis and Haemostasis|January 1, 1997
Coagulation and fibrinolysis factors in healthy subjects consuming high stearic or trans fatty acid dietsM Mutanen, A AroGenome Research|January 10, 1998
Steady-state transcript levels of the porphobilinogen deaminase gene in patients with acute intermittent porphyriaS Mustajoki, R Kauppinen, P Mustajoki, et al.Human Molecular Genetics|February 1, 1995
Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase geneR Kauppinen, S Mustajoki, H Pihlaja, et al.Clinical Pharmacology and Therapeutics|July 1, 1994
Effects of heme arginate on cytochrome P450-mediated metabolism of drugs in patients with variegate porphyria and in healthy menP Mustajoki, S Mustajoki, A Rautio, et al.Diabetic Medicine : a Journal of the British Diabetic Association|July 27, 2001
Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre studyS Madsbad, B Kilhovd, I Lager, et al.Postgraduate Medical Journal|January 1, 1975
Inheritance of endogenous hypertriglyceridaemia type IIB or IVE A Nikkilä, A AroThe Journal of Clinical Investigation|August 1, 1985
Acute intermittent porphyria: characterization of a novel mutation in the structural gene for porphobilinogen deaminase. Demonstration of noncatalytic enzyme intermediates stabilized by bound substrateR J Desnick, L T Ostasiewicz, P A Tishler, et al.Trials|November 30, 2021
Prevention of leg cramps by using compression stockings or magnesium supplements in the 50-84 age group: study protocol for a randomised controlled trialJenni Joensuu, Pertti P Mustajoki, Pekka K Mustonen, et al.Pageof 22